Introduction {#s1}
============

B4GALT5, also known as β-1, 4 galactosyltransferase V, is one of β-1, 4 galactosyltransferase (B4GALT) family including seven members (Zhou et al., [@B54]). B4GALT is one of the most studied glycosyltransferases in recent years. These enzymes catalyze the shift of galactosyl group from UDP galactoside to N-acetylglucosamine or other glycosyl acceptor to determine the biosynthesis of different glycoconjugates (Zhang et al., [@B53]). Current research has shown that β-1, 4 galactosyltransferases are concerned with embryonic development (Kumagai et al., [@B25]), neurological development (Shen et al., [@B35],[@B36]), immune and inflammatory responses (Parker et al., [@B32]), tumor generation and development (Shirane et al., [@B37]), and other life activities (Wei et al., [@B48]) and diseases (Cartault et al., [@B8]). However, substrate specificity and distribution in different tissues of the members of the β-1, 4 galactosyltransferase family determine their functional differences (Fan et al., [@B12]; Ujita et al., [@B43]). At present, the functional aspect of β4Ga1T1 is the most studied, followed by β4Ga1T5.

Glycosylation is a common phenomenon in living organisms (Al-Ghouleh et al., [@B1]; Tavares-Carreón et al., [@B41]). Glycosyltransferases (glycosyltransferases, GT, EC 2.4.x.y) are specifically responsible for catalyzing the glycosylation and are the most diverse in nature (Terasaka et al., [@B42]; Schmid et al., [@B34]). The neck region of β4GalT5 contains multiple conserved N-glycosylation sites, it preferentially participates in N-linked galactosylation, but also catalyzes galactosylation of O-sugar chains (Furukawa, [@B13]). The phenomenon of viral protein glycosylation is widespread (DeVito et al., [@B10]; Bagdonaite et al., [@B5]), glycoproteins are necessary to the proliferation cycle of virus, recognition of host cells (Wasik et al., [@B47]) and viral fusion envelope-mediated with host cells (Khan et al., [@B23]).

Porcine reproductive and respiratory syndrome virus (PRRSV) is an *Arterivirus* of the family *Arterivirdae*. It has been determined that it is a single-stranded positive strand RNA with encapsulated membrane virus (Snijder et al., [@B38]). Sow breeding disorders, piglet respiratory symptoms and high mortality rate as the incidence characteristics (Bautista et al., [@B7]). The PRRSV genome is 15 kb long and contains eight Open Reading Frames (ORFs), ORF1 encodes the viral non-structural protein, ORF2\~ORF7 encodes structural protein of the virus, the expression products of ORF2 \~5 are glycosylated envelope protein (Glycoprotein, GP 2\~5), ORF6 and ORF7 encode membrane matrix proteins (M) and the nucleocapsid protein (N) (Conzelmann et al., [@B9]). Among these, GP5 is one of the highest degree of variations, but also is the main structure of PRRSV capsule glycoprotein, it is necessary to the infectivity and proliferation of PRRSV (Gao et al., [@B15]). Although the role of B4GALT5 in many different areas has been reported, it remains unknown whether it regulates the proliferation of capsular virus. In our research, we triumphantly acquired the porcine B4GALT5 (pB4GALT5) gene from porcine alveolar macrophages and compared evolutionary relationship between species based on amino acid sequence analysis. The effect of pB4GALT5 on proliferation of PRRSV was also surveyed. Our experiments would provide a basis for further revealing the function of GP5 protein glycosylation in viral replication and activation of immune responses.

Materials and methods {#s2}
=====================

Cells and virus
---------------

Porcine alveolar macrophages (PAM) cell line 3D4/21 grown in RPMI-1640 medium (Gibco) added with 10% fetal bovine serum (FBS) (Biological Industries). Hela cells grown in Dulbecco\'s modified Eagle\'s medium (DMEM) added with 10% FBS, 100 U/ml penicillin and 10 μg/ml streptomycin sulfate in a 37°C, 5% CO~2~ incubator. The stock of PRRSV-JXwn06 with a titer of 10^4^TCID50/ml was used in this research.

RT-PCR amplification of complete CDS of porcine B4GALT5 gene
------------------------------------------------------------

A pair of oligonucleotide primer (listed in Table [1](#T1){ref-type="table"}) was designed based on the coding sequence (CDS) of predicted pB4GALT5 sequence (NCBI Reference Sequence: [XR_002340099.1](XR_002340099.1)). Intracellular RNA were abstracted using TRIzol from TaKaRa. RAN were reverse transcript by reverse transcription kit (TaKaRa). The cycler program was consisted with 95°C for 5 min, then 30 cycles at 95°C for 30 s, 56°C for 30 s and 72°C for 1.2 min using 2 × PCR Solution Premix Taq™ from TaKaRa.

###### 

Primers used in amplification and plasmid construction.

  **Primer[^a^](#TN1){ref-type="table-fn"}**   **Sequence (5′-3′)[^b^](#TN2){ref-type="table-fn"}**   **Product size**   **Use**
  -------------------------------------------- ------------------------------------------------------ ------------------ ---------------
  1F                                           CG*GAATTC*AATGCGCGTCCGCCGGGGG                          1,167bp            Flag-B4GALT5
  1R                                           GC*TCTAGA*TCAGTACTCGGTCACCTGAG                                            
  2F                                           CG*GAATTC*ATGCGCGTCCGCCGGGGGC                          1,167bp            B4GALT5-DsRed
  2R                                           GG*GGTACC*GTGTACTCGGTCACCTGAGC                                            
  3F                                           CG*GAATTC*ATGTTGGGGAAATGCTTG                           603bp              GP5-Myc
  3R                                           CC*CTCGAG*AGGACGACCCCATTGTTC                                              
  4F                                           CC*CTCGAG*CTATGTTGGGGAAATGCTTG                         603bp              GFP-GP5
  4R                                           GG*GGTACC*CTAAGGACGACCCCATTG                                              

*F/R meant upstream/downstream primers*.

*Dash indicated restriction sites*.

Bioinformatics analyses and sequence alignment
----------------------------------------------

Bioinformatics analyses include protein structure analyses and functional domain analyses. Transmembrane region analyses was conducted using online software CBS Prediction Servers (<http://www.cbs.dtu.dk/services/TMHMM-2.0/>). Protein secondary structure was predicted using the PHYRE 2 online soft (<http://www.sbg.bio.ic.ac.uk/phyre2/html/>). Then, we imitated 3D structure using online website (<http://zhanglab.ccmb.med.umich.edu/I-TASSER/>). I-TASSER was an abbreviation of Iterative Threading AS Assembly Recession. It was a hierarchical approach to forecast structures and functions of multiple proteins. It would recognize the structural template from the Protein Data Bank (PDB) through the multi-threaded method LOMETS, which built a full-length atomic model through iterative template fragment simulated atomic assembly. The 3D model was then threaded through the BioLiP for ligand-protein binding database to insight into the function of the target protein. Subsequently, I mapped its critical domains using PyMOL software (<https://pymol.org/2/>). Amino acid sequences were aligned using the DNAMAN program (<http://www.lynnon.com/dnaman.html>). Meanwhile, sequence similarity analyses were conducted using the MEGA5.0 (<http://www.megasoftware.net>).

Plasmid constructions
---------------------

The cDNA of pB4GALT5 was amplified and sub-cloned into the vector pFlag-CMV-2 (Sigma-Aldrich) and pDsRed-Monomer-N1 (Clontech) to generate the fusion plasmid of B4GALT5-DsRed and Flag- B4GALT5. The GP5 gene of PRRSV JXwn06 was amplified and cloned into the vector pcDNA3.1 (Invitrogen) and pEGFP-C1 (Clontech) to generate the plasmid of GP5-Myc and GFP-GP5. Above constructs were verified by sequencing and the sequences of primers were supplied in Table [1](#T1){ref-type="table"}.

Transcriptome sequencing and analysis
-------------------------------------

3D4/21 cells were cultured in 10 cm culture dish at 10^6^ cells/ml. After cells were grown to monolayer and were incubated with PRRSV at 0.5 MOI for 24 h. And then we washed twice with 1 × phosphate-buffered saline (PBS) and add 1 ml of Trizol to lyse cells. The cells were then transferred to a cryopreserved tube and sent to Guangzhou GENE DENOVO Company for transcription sequencing.

The specific operation flow is as follows. After extracting the total RNA, the mRNA was enriched with the magnetic beads with Oligo (dT). To add the fragmentation buffer so that mRNA becomes a short segment. And then the first strand was synthesized by random hexamers using fragmented mRNA as template, the addition of buffer, dNTPs, RNase H and DNA polymerase I synthesis cDNA secondary chain. Following, the acquired cDNA was purified and eluted by QiaQuick PCR kit and EB buffer. Next, to add base A, and sequencing linkers after the ends were repaired. And then the purpose fragments were recovered by agarose gel electrophoresis, and PCR amplification was carried out to complete the whole library preparation. The constructed library was sequenced with Illumina HiSeqTM 2500.

The obtained transcriptome data were analyzed using online website (<http://www.omicshare.com/tools/Home/Soft/search>) and drawn a heat map to show the differential expression of the gene.

Quantitative real-time PCR (qRT-PCR)
------------------------------------

The comparatively quantification of gene expression level was measured by qRT-PCR run on ABI 7500 Real-Time PCR system, the thermal cycler program consisted of 95°C for 10 min, then 40 cycles at 95°C for 15 s, 55°C for 30 s and 72°C for 30 s using DBI Bioscience-2043 Bestar SybrGreen qPCR mastermix. All the primers were shown in Table [2](#T2){ref-type="table"}.

###### 

Primers used in quantitative real-time PCR.

  **Gene**   **Accession no**.                  **Primer sequence (5′-3′)**   **Product (bp)**   **Tm (°C)**
  ---------- ---------------------------------- ----------------------------- ------------------ -------------
  B4GALT5    [XM_003134490.4](XM_003134490.4)   AACAGTTTCGGAAAATCAATGGC       196                56.4
                                                TTCCTCAGCAGGGCATACCTT                            
  GP2a       [JX317649.1](JX317649.1)           CTACCCATGCTGCACAACC           260                55.4
                                                AGAAAAGTTGCCCCTAACCAG                            
  GP3        [JX317649.1](JX317649.1)           CACCTTGCCTCGCCATGACA          292                57.4
                                                ACTGAGAACTTTTGCGAATCGT                           
  GP4        [JX317649.1](JX317649.1)           CTCTCCGACGATTCGCAAA           275                55.6
                                                CATGATCGACCACTAAGGAGC                            
  GP5        [JX317649.1](JX317649.1)           CCAGCCATTTCCTTGACACA          285                56.0
                                                ACAACTCTCTTGAGGTCGAT                             
  N          [JX317649.1](JX317649.1)           GCCCAGCAAAACCAGTCC            256                58.4
                                                GCGTTGGCAGACTAAACT                               
  β-actin    [DQ452569.1](DQ452569.1)           GAATCCTGCGGCATCCACGA          230                55.0
                                                CTCGTCGTACTCCTGCTTGCT                            
  MHCI       [NM_001097431](NM_001097431)       CACGGCGGCTCAGATCACCA          288                58.6
                                                GTCTCCACCAGCTCCATGTCC                            
  MHCII      [NM_001113695](NM_001113695)       ATTAAACGTTCCAACAACACCG        296                56.3
                                                TTATCCAGGCCCCAGTGCTC                             
  IFN-α      [JQ839262.1](JQ839262.1)           TGAGAGCCTCCTGCACCA            267                56.0
                                                CTTCTGCCCTGACGATCTC                              
  IL-6       [AF518322.1](AF518322.1)           TACTGGCAGAAAACAACC            294                58.3
                                                TCTGTGACTGCAGCTTATC                              
  IL-18      [AF191088.1](AF191088.1)           TACACTTTACTTTGTAGCTGA         305                56.5
                                                TAGACATTTTCTTACACTGC                             
  IL-1β      [M86725.1](M86725.1)               AGAGCATCTTTTCATCCGTCT         253                57
                                                GTCACAGGTATCTTGTCATCG                            
  TNF-α      [X57321.1](X57321.1)               GCTGCCCTTCCACCAACGTTT         203                58.4
                                                CTCGGCACTGAGTCGATCATCC                           
  MCP-1      [AJ311717.1](AJ311717.1)           CTCCTGTGCCTGCTGCT             282                55
                                                TTCAAGGCTTCGGAGTTT                               
  CCR2       [AB119271.1](AB119271.1)           AACATTCTGGTTACGCCTGT          124                52.7
                                                ATTCCCGAGTAGCAGACG                               
  LFA1       [NM_213908.1](NM_213908.1)         GAAGTTCGACACCGGCCCCTT         254                63.4
                                                TGCCCACGAGCACGACTCCC                             
  ICAM1      [NM_213816.1](NM_213816.1)         TCCTGTATGGACCCCGGCTA          256                58.0
                                                TGGATCACGTTCACGACCAC                             

The data processing employed the relative cycle threshold (CT), that is 2^−ΔΔCt^ method, and ΔΔCt was calculated according to the following formula:
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The calculation results were the relative expression amount of the genes, so as to eliminate the interference of the irrelevant foreign protein expression as much as possible and reduce the experimental error.

Flow cytometry assay
--------------------

To determine the expression of pB4GALT5, 3D4/21 cells were dealt with PRRSV strain JXwn06 at 0.5 MOI or mock infected with DMEM. Twenty four hours after inoculation, the 3D4/21 cells were washed twice with PBS to suck away dead cells, separated from the dishes with trypsin at 37°C for 5 min, and then rinsed three times with cold PBS. The cells were used for staining with murine polyclonal antibody of B4GALT5 at 4°C for 30 min and then incubated with anti-mouse IgG with FITC (BD pharmingen™) (1:200) for 30 min at 4°C. By flow cytometry, a total of 2 × 10^4^ cells were detected, and fluorescence intensity was viewed as the expression of pB4GALT5.

TCID~50~ assay in regard to PRRSV titers
----------------------------------------

PRRSV titers were evaluated by a doubling dilution assay and the titers were denoted as the 50% cells culture infective dose (TCID~50~)/ml through the Reed-Muench method (Wang et al., [@B46]). In short, 3D4/21 cells were scattered in 96-well plates, following, incubated with serial 10-fold dilutions (100 μl) of the primary PRRSV and set two column repeats for each dilution. Allow virus to adsorb to cells at 37°C for 1 h, then, the virus inoculum was sucked away, and RPMI-1640 adding 2% FBS. Cells were incubated for 48--72 h. Virus titers were calculated by determining the dilution of 50% cells culture infective dose that reveal cytopathic appearances.

Small RNA (siRNA) interfering assay
-----------------------------------

For evaluating regulation of B4GALT5 on proliferation of PRRSV and expression of immune-related molecules, a siRNA assay was carried out by utilizing siRNA for B4GALT5 (siB4GALT5) and negative control (NC) that were synthesized though GenePharma (Tianjin, China; Table [3](#T3){ref-type="table"}). The siRNAs were transfected at 50 nmol using Lipofectamine3000 (Invitrogen) for 24 h. Then, cells were dealt with the PRRSV at 0.5 MOI for 24 h. Quantitative real-time PCR and Western blot analyses were performed to confirm the expression levels.

###### 

Primers used in small RNA interfering assay.

  **Gene**           **Accession no**.    **Primer sequence (5′-3′)**
  ------------------ -------------------- -----------------------------
  Negative control   NC                   F:UUCUCCGAACGUGUCACGUTT
                                          R:ACGUGACACGUUCGGAGAATT
  siB4GALT5-1        [Sus-236](Sus-236)   F:GCGUGAACGACUCAGACUATT
                                          R:UAGUCUGAGUCGUUCACGCTT
  siB4GALT5-2        [Sus-448](Sus-448)   F:GGAGGUCACUGGAAGCCAUTT
                                          R:AUGGCUUCCAGUGACCUCCTT

Confocal immunofluorescence assay
---------------------------------

Flag-B4GALT5 and GP5-myc were transfected into Hela cells by Lipofectamine™ 2000 (Invitrogen). 4% paraformaldehyde fixed cells for 30 min, and then, respective primary antibodies dealt with cells for 1 h. Tris buffered saline-tween-20 (TBST) washed twice, anti-rabbit IgG- FITC or anti-mouse IgG- Cy5 dealt with cells for 2 h under indoor temperature. Nuclei were stained with DAPI. At last, the photographs were visualized by a PerkingElmer (America) laser confocal imaging analysis system after nuclear staining.

In addition, 3D4/21 cells were co-transfected with GFP-GP5 and B4GALT5-DsRed, GFP-Golgi marker (received from Tianjin Medical University epigenetic laboratory) and B4GALT5-DsRed. The cells at 36 h post-transfection were fixed and cellular nuclei were stained with DAPI. The rest of the treatment was the same as above.

Co-immunoprecipitation and western blot
---------------------------------------

GP5-myc and Flag-B4GALT5 were transfected for 48 h in 3D4/21 cells. Following, they were lysed with lysis buffer (APPLYGEN, Beijing, China). To separate cell lysates at 13,000 rpm for 8 min though centrifugation. Then, mouse anti-Flag mAb Sepharose beads (Sigma) added to supernatants and incubated 2 h, the sediments were gathered and the beads were washed twice using lysis buffer. Proteins were transferred from SDS-PAGE to a piece of nitrocellulose membrane (NC) (ExPro). The membrane was dealt with mouse anti-Myc antibody, and goat anti-mouse IgG with horseradish peroxidase, and detected though chemiluminescence detection kit (Thermo Scientific, USA) and was viewed though Gel Imaging System (BIO-RAD, USA).

Statistical analysis
--------------------

Above experiments were carried out with three independent replicates. Results were dealt with GraphPad Prism software using *t*-test. Error was signed as the standard error of the mean (SEM). Differences in data were taken for be statistically significant if the *P*-value was less than 0.05 (^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*^*p* \< 0.001).

Result {#s3}
======

Porcine B4GALT5 expression was up-regulated in 3D4/21 cells by PRRSV infection
------------------------------------------------------------------------------

A transcriptome analysis derived from the 3D4/21 cells was carried out for looking for related genes about signaling pathways and anti-viral immunity that had a significant change in the level of transcription after PRRSV infection, and also compared with other transcript data (Jiang et al., [@B22]; Islam et al., [@B19]). According to the data analysis, 3,815 genes were up-regulated after PRRSV infection and 2,435 genes were down-regulated (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). B4GALT5 was found to be significantly upregulated among the glycosyltransferase genes after viral infection (Figure [1A](#F1){ref-type="fig"}). The results showed that the cellular B4GALT5 might have a certain relationship with the proliferation of the virus, which was selected for further study.

![Porcine B4GALT5 expression was up-regulated during PRRSV infection. **(A)** The heatmap of glycosyltransferase-related differentially expressed genes. **(B)** 3D4/21 cells were mock-infected or infected with PRRSV at a multiplicity of infection (MOI) of 0.5. Cells were collected at the indicated time points, and subjected to real-time RT-PCR to analyze the expression of porcine B4GALT5. **(C)** 3D4/21 cells were mock-infected or infected with PRRSV at a multiplicity of infection (MOI) of 0.5. Cells were collected at the 24 h. Flow cytometry analysis of B4GALT5 protein expression levels. Differences in data were taken for be statistically significant if the *P*-value was less than 0.05 (^\*^*p* \< 0.05; ^\*\*\*^*p* \< 0.001).](fcimb-08-00048-g0001){#F1}

To verify whether PRRSV activates the expression of pB4GALT5, the mRNAs of pB4GALT5 from 3D4/21 cells infected with PRRSV of 0.5 MOI were detected by qRT-PCR. The transcription of pB4GALT5 was enhanced from 12 to 36 h than the untreated control (Figure [1B](#F1){ref-type="fig"}). The protein expression of pB4GALT5 was upregulated (Figure [1C](#F1){ref-type="fig"}). The above results testified that PRRSV upregulated pB4GALT5 expression in 3D4/21 cells.

Domain and sequence analysis of porcine B4GALT5
-----------------------------------------------

Porcine B4GALT5 gene (complete CDS) was submitted to the GenBank ([KY565579.1](KY565579.1)). And then, the gene encoded 388aa and existed transmembrane domains (Supplementary Figure [2](#SM1){ref-type="supplementary-material"}). The pB4GALT5 protein included ligand binding sites, alpha helix, and beta strand.

Like the other members of the B4GALT family, pB4GALT5 contained four domains: a cytoplasmic domain (1--12 aa of N-terminal) including abundant amino acids with positive charges; a transmembrane domain (TMD) (13--35 aa), which was rich in hydrophobic amino acids; a neck region (36--160 aa), which located in the Golgi apparatus lumen, containing glycine and proline residues; and a catalytic domain (161--388 aa), which was the largest and most important functional domain for pB4GALT5 in the lumen (Supplementary Figure [3A](#SM1){ref-type="supplementary-material"}). Little was known with respect to the 3D structures of pB4GALT5. So, we modeled its protein 3D structure using Zhang Lab\'s I-TASSER. And the key part (161--388 aa) containing ligand binding sites was shown in Figure [2A](#F2){ref-type="fig"}.

![Domain and sequence analysis of porcine B4GALT5. **(A)** Protein 3D structure simulation using Zhang Lab\'s I-TASSER, PHYRE 2 online server and PyMOL software. The key amino acid sites that could bind ligand substrates were labeled (left) with different colors. **(B)** B4GALT5 phylogenetic tree of a range of species. Porcine B4GALT5 was indicated by a solid triangle, and all other B4GALT5 sequences were obtained from GeneBank. The unrooted phylogenetic tree was generated using neighbor-joining method by MEGA 5.0 software with 1,000 replications for bootstrap analysis and based on the alignment of B4GALT5 amino acid sequences. The scale bar is 0.02. **(C)** The amino acid sequence diagram of the family of porcine β-1, 4 galactosyltransferase, the homology was very low.](fcimb-08-00048-g0002){#F2}

The pB4GALT5 shared a high amino acid sequence similarity with homo sapiens B4GALT5 (hB4GALT5: NM_004776.3) and bos taurus B4GALT5 (bB4GALT5:XM_015466213.1) at 96.4 and 95.9%, respectively, but showed a relatively lower identity with danio rerio B4GALT5 (dViperin: NM_001045332.1) at 69.1% (Supplementary Figure [3B](#SM1){ref-type="supplementary-material"}). The phylogenetic analysis revealed that pB4GALT5 might share a common ancestry with Homo sapiens and Mus muscluls. However, pB4GALT5 exhibited a relatively low identity to aves and pisces class (Figure [2B](#F2){ref-type="fig"}). To identify the differences in the amino acid sequence of the porcine B4GALT family, B4GALT1-7 amino acid sequences deriving from the NCBI database were aligned using DNAMAN software and the results were displayed using IBS (Illustrator for Biological Sequences) software (<http://ibs.biocuckoo.org/>). Obviously, B4GALT1 had the longest amino acid sequence and B4GALT7 had a short amino acid sequence. In addition to B4GALT7, they contained multiple conserved cysteine sites and four kind of conserved segments. Moreover, they were predicted to contain transmembrane domain except B4GALT4 (Figure [2C](#F2){ref-type="fig"}). Since the amino acid sequence of B4GALT4 was partial CDS, therefore, the analysis of the B4GALT4 only as a reference.

Porcine B4GALT5 locates in the Golgi apparatus
----------------------------------------------

It has been reported that human β-1, 4 galactosyltransferase belongs to type II membrane binding protein, mainly located in the Golgi apparatus (Rodeheffer and Shur, [@B33]). It is a single transmembrane protein, the amino-terminus is located in the cytoplasm, and the carboxyl-terminus is located in the Golgi lumen (Park et al., [@B31]).

To investigate the location of porcine B4GALT5, we co-transfected the recombinant plasmids (GFP-Golgi marker protein and B4GALT5-DsRed) into 3D4/21 cells, the operation methods are listed in Materials and Methods. The results suggested that the fuse protein B4GALT5-DsRed had a co-located and gathered phenomenon with Golgi marker protein (Figure [3](#F3){ref-type="fig"}).

![Subcellular localization analysis of porcine B4GALT5. 3D4/21 cells were transfected with GFP-Golgi marker and B4GALT5-DsRed. Cells were fixed and permeabilized at 24 h post-transfection. Cellular nuclei were stained with DAPI. The porcine B4GALT5 localization was observed under a laser confocal imaging analysis system, scale bar: 14 μm.](fcimb-08-00048-g0003){#F3}

The over-expression of B4GALT5 slightly inhibited the proliferation of PRRSV in 3D4/21 cells
--------------------------------------------------------------------------------------------

Firstly, western blot was implemented to examine Flag-B4GALT5 expression level in 3D4/21 cells transfected with Flag-B4GALT5 recombinant plasmid. As shown in Figure [4A](#F4){ref-type="fig"}, the expression of Flag-B4GALT5 could be observed. 3D4/21 cells that were expressing Flag-B4GALT5 were infected with PRRSV, the expression levels of virus protein and virus titers were analyzed after 24 h. As shown in Figure [4B](#F4){ref-type="fig"}, the transcription levels of virus envelope glycosylated-proteins (GP2a, 3, 4, 5) and structural protein (N) have different degrees of decline. Moreover, we also examined the viral non-structural protein (Nsp2) at protein levels, the results showed that Nsp2 protein expression could be inhibited slightly (Figure [4C](#F4){ref-type="fig"}). Furthermore, as shown in Figure [4D](#F4){ref-type="fig"}, the virus titers after the over-expression of pB4GALT5 were statistically down-regulated at 24 h after infection. All results indicated that the up-regulation of B4GALT5 inhibited the proliferation of PRRSV in 3D4/21 cells.

![Inhibition of PRRSV replication by B4GALT5 over-expression in 3D4/21 cells. **(A)** The expression of Flag-B4GALT5 in 3D4/21 cells. 3D4/21 cells were transfected with Flag-B4GALT5 or empty vector as negative control. The Flag-B4GALT5 and empty vector were detected with a mouse anti-Flag mAb. β-actin was detected as an internal control using a mouse anti-β-actin mAb. **(B,C)** 3D4/21 cells were transfected with Flag-B4GALT5 or empty vector. Twenty-four hours after transfection, cells were infected with PRRSV (MOI 0.5). The infected cells were collected at 24 h post-infection, mRNA loads of viral structural genes (GP2a,GP3,GP4,GP5,N) were tested by qRT-PCR, and viral nonstructural protein (Nsp2) were tested by WB. **(D)** Next, PRRSV-containing samples were tested by TCID50 assay. All data represented the means and standard deviation of three independent experiments. Differences in data were taken for be statistically significant if the *P*-value was less than 0.05 (^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01).](fcimb-08-00048-g0004){#F4}

Silencing of B4GALT5 improved the proliferation of PRRSV in 3D4/21 cells
------------------------------------------------------------------------

Firstly, we verified the silence of pB4GALT5 in 3D4/21 cells by western blot and qRT-PCR after the cells were dealt with the final concentration of 50 nmol of two siRNAs (Sus-236 and Sus-448) targeting for B4GALT5 gene and negative control (NC) (Table [3](#T3){ref-type="table"}). The results certified that the B4GALT5 expression could be restrained by two siRNAs (Figures [5A--C](#F5){ref-type="fig"}).

![Silencing of B4GALT5 by siRNA improved the replication of PRRSV in 3D4/21 cells. **(A--C)** Silencing efficiency of B4GALT5 gene with three siRNAs (Sus-236, Sus-448 and NC) at the final concentration of 50 nmol. The expression level of B4GALT5 was examined at 48 h post-transfection by qRT-PCR and Western blot with a mouse anti-B4GALT5 mAb, β-actin was detected as an internal control using a mouse anti-β-actin mAb. **(D)** PRRSV titers in the supernatants of B4GALT5 gene-silenced 3D4/21 cells. 3D4/21 cells were transfected with Sus-236, Sus-448 and NC at a final concentration of 50 nmol, and were then infected at 24 h post-transfection with PRRSV at MOI of 0.5. The virus titers in the supernatants were assayed. **(E,F)** The PRRSV-infected and B4GALT5 gene-silenced 3D4/21 cells were collected at 24 h post-infection, mRNA loads of viral structural genes (GP2a,GP3,GP4,GP5,N) were tested by qRT-PCR, and viral nonstructural protein (Nsp2) were tested by Western Blot. Differences in data were taken for be statistically significant if the *P*-value was less than 0.05 (^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*^*p* \< 0.001).](fcimb-08-00048-g0005){#F5}

The 3D4/21 cells were incubated with PRRSV after transfected with the siRNA, and the mRNA and expression level of virus genes were assayed after infection. The results proved that mRNA and expression level of the siRNA-transfected cells were significantly high (Figures [5E,F](#F5){ref-type="fig"}). Additionally, the virus titers were statistically up-regulated (Figure [5D](#F5){ref-type="fig"}), indicating that silencing of B4GALT5 improved the proliferation of PRRSV in 3D4/21 cells.

Porcine B4GALT5 interacted with the GP5 of PRRSV
------------------------------------------------

Co-IP was carried out to verify the interaction between B4GALT5 and GP5. GP5-Myc and Flag-B4GALT5 were transfected to 3D4/21 cells. The Myc-tagged and Flag-tagged was detected with respective antibody by Western blot. The results showed that Flag-B4GALT5 could interact with GP5-Myc (Figure [6A](#F6){ref-type="fig"}). Additionally, the molecular weight of GP5-Myc increased and strip widened after the co-transfection of Flag-B4GALT5 and GP5-Myc (Figure [6B](#F6){ref-type="fig"}), indicating that GP5 was likely to be glycosylated by B4GALT5.

![Identification of the interaction between pB4GALT5 and the GP5 of PRRSV. **(A)** Shown is the interaction of B4GALT5 with GP5 by Co-IP. 3D4/21 cells were co-transfected with the indicated plasmids. Thirty-six hours after transfection, the cell lysates were precipitated with an anti-Flag mAb in conjunction with protein A Sepharose, and further detected by Western blot with an anti-Flag mAb and an anti-Myc antibody, respectively. **(B)** Shown is the molecular weight of GP5-Myc increased and strip widened after the co-transfection of Flag-B4GALT5 and GP5-Myc by Western blot with an anti-Myc antibody. **(C)** Hela cells were co-transfected with GP5-Myc and Flag-B4GALT5. The cells at 36 h post-transfection were fixed and double-stained with a rabbit anti-Myc mAb and a mouse anti-Flag antibody, and followed by FITC-conjugated anti-rabbit IgG (green) and Cy5-conjugated anti-mouse IgG (red). Nuclei were stained with DAPI (blue). **(D)** 3D4/21 cells were co-transfected with GFP-GP5 and B4GALT5-DsRed. The cells at 36 h post-transfection were fixed and cellular nuclei were stained with DAPI. Above co-localizations were observed under a laser confocal imaging analysis system, scale bar: 14 μm.](fcimb-08-00048-g0006){#F6}

To determine whether B4GALT5 co-localized with GP5, GP5-Myc and Flag-B4GALT5 were transfected to Hela cells, and were detected at 36 h after transfection though laser confocal imaging analysis system. The photos declared that B4GALT5 and GP5 co-localized among the cytoplasm (Figure [6C](#F6){ref-type="fig"}). Moreover, the co-localization between GP5 and B4GALT5 was also observed in 3D4/21 cells co-transfected with GFP-GP5 and B4GALT5-DsRed (Figure [6D](#F6){ref-type="fig"}). In addition, we also explored the interaction between other GP and B4GALT5, but found no obvious co-localization phenomenon (Supplementary Figure [4](#SM1){ref-type="supplementary-material"}).

The over-expression of B4GALT5 facilitated the expression of immune-related molecules in 3D4/21 cells
-----------------------------------------------------------------------------------------------------

3D4/21 cells over-expressed Flag-B4GALT5 (Figure [7A](#F7){ref-type="fig"}) that were then infected with the PRRSV at 0.5 MOI, the transcription of immune-related molecules produced by macrophages were upregulated with varying degrees by qRT-PCR, including interferon-α, interleukin (IL-6, 18) and other inflammatory factors (IL-1β, TNF-α), cell adhesion molecules (LFA-1, ICAM-1), chemokines (MCP-1, CCR2), and antigen presenting molecules (MHC-I, MHC-II) (Figures [7B--E](#F7){ref-type="fig"}).

![Facilitation of immune-related molecules expression by B4GALT5 over-expression in 3D4/21 cells. **(A)** The expression of Flag-B4GALT5 in 3D4/21 cells. 3D4/21 cells were transfected with Flag-B4GALT5 or empty vector as negative control. The Flag-B4GALT5 and empty vector were detected with a mouse anti-Flag mAb. β-actin was detected as an internal control using a mouse anti-β-actin mAb. **(B--E)** Analysis of transcription and expression of different cytokines produced by macrophages via qRT-PCR. **(F--H)** Protein expression levels of MHC-I, II by flow cytometry analysis and western blot. All data represented the means and standard deviation of three independent experiments. Differences in data were taken for be statistically significant if the *P*-value was less than 0.05 (^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*\*^*p* \< 0.0001).](fcimb-08-00048-g0007){#F7}

The reasons for choosing these factors include the following two aspects. On the one hand, these immunomodulatory molecules were mainly produced in porcine macrophages (3D4/21) and involved in antigen presentation and anti-viral immunity. The B4GALT family involved in the inflammatory response, so inflammatory factors were also selected as the test subjects. On the other hand, they were cytokines or inflammatory factors that contain glycosylation sites. B4GALT5 encoded glycosyltransferase, we would like to explore whether B4GALT5 had an impact on the transcription and expression of glycoprotein-like immunomodulatory molecules.

Moreover, the glycosylated-protein expression of MHC-I, II were also promoted by over-expression of pB4GALT5 in 3D4/21 cells by flow cytometry assay and western blot (Figures [7F--H](#F7){ref-type="fig"}). Above results indicated that the over-expression of B4GALT5 facilitated the expression of glycosylated- immune molecules on cell surface in order to better resist the invasion of the virus.

Silencing of B4GALT5 by siRNA suppressed the expression of immune-related molecules in 3D4/21 cells
---------------------------------------------------------------------------------------------------

3D4/21 cells that were treated with the final concentration of 50 nmol of two siRNAs (Sus-236 and Sus-448) targeting for B4GALT5 gene and negative control (NC) (Figure [8A](#F8){ref-type="fig"}), and then were incubated with PRRSV at 0.5 MOI, the transcription of immune-related molecules produced by macrophages were down-regulated with varying degrees by qRT-PCR, including interferon-α, interleukin (IL-6,18) and other inflammatory factors (IL-1β,TNF-α), cell adhesion molecules (LFA-1,ICAM-1), chemokines (MCP-1,CCR2), and antigen presenting molecules (MHC-I, MHC-II) (Figures [8B--E](#F8){ref-type="fig"}). Moreover, the glycosylated-protein expression of MHC-I, II were also suppressed in 3D4/21 cells by flow cytometry assay and western blot (Figures [8F--H](#F8){ref-type="fig"}), indicating that the silencing of B4GALT5 may affect the expression of immune-related factors thereby inhibiting their antiviral effects.

![Silencing of B4GALT5 by siRNA suppressed immune-related molecules expression in 3D4/21 cells. **(A)** Silencing efficiency of B4GALT5 gene with three siRNAs (Sus-236, Sus-448 and NC) at the final concentration of 50 nmol. The expression level of B4GALT5 was examined at 48 h post-transfection by qRT-PCR. **(B--E)** The PRRSV-infected and B4GALT5 gene-silenced 3D4/21 cells were collected at 24 h post-infection, mRNA loads of immune-related molecules produced by macrophages were tested by qRT-PCR, **(F--H)** and antigen presenting molecules (MHC-I, MHC-II) were tested by flow cytometry analysis and western blot. Differences in data were taken for be statistically significant if the *P*-value was less than 0.05 (^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*^*p* \< 0.001; ^\*\*\*\*^*p* \< 0.0001).](fcimb-08-00048-g0008){#F8}

Discussion {#s4}
==========

The glycosyltransferase was present in the post-translational modification of the protein, and the virus invaded the host cells and used the ribosomes, endoplasmic reticulum and Golgi in the host cells to translate and modify the self-structural proteins (Mardassi et al., [@B28]; Goodwin et al., [@B16]). β-1, 4 galactosyltransferase V carries out modification of important protein sugar chain in the Golgi through the synthesis of β-1,4 glycosidic bonds (Evans et al., [@B11]). β4GalT5 regulated the expression of Lewis-Y polysaccharides that played an important role in the embryo implantation process (Gu et al., [@B17]). Deletion of β4Ga1T5 might cause inhibition of lactose ceramide synthesis to lead placental developmental defects in mouse (Kumagai et al., [@B25]; Nishie et al., [@B30]). In mature 3T3-L1 adipocytes, TNF-α-induced insulin resistance was accompanied by a variety of changes in the sugar chain structure, including the increase in the expression of β4GalT5, suggesting that β4GalT5 might also be involved in the inflammatory response process (Parker et al., [@B32]). Overexpression of β4Ga1T5 could promote the invasion and survival of glioma cells, while inhibition of expression could promote apoptosis, inhibition of migration and invasion and tumor formation in nude mice (Jiang and Gu, [@B20]). Up to now, most studies about B4GALT5 concentrated mainly on human, rat, and mouse (Al-Obaide et al., [@B2]). However, no identified reports related to pig, *Sus scrofa*, was available. We firstly acquired complete CDS of pB4GALT5 and predicted structures. We also made the domain analyses and alignment and, indicating that pB4GALT5 shared a high identity with *Homo sapiens* and included a cytoplasmic domain, a neck region, a transmembrane domain and C-terminally catalytic domain. These findings laid the foundation for the study of its function.

The glycoproteins of the enveloped viruses and the glycoproteins in the host cell could utilize the same glycosyltransferases during protein glycosylation. To explore the relationship between β4Galt5 and the proliferation of enveloped viruses, we detected the transcription and protein levels of B4GALT5 in PRRSV-infected 3D4/21 cells. As shown as Figures [1B,C](#F1){ref-type="fig"}, the result indicated that PRRSV infection up-regulated pB4GALT5 expression in 3D4/21 cells. Here we proposed the hypothesis that β4Galt5 might be involved in the regulation of viral proliferation in 3D4/21 cells.

It had been reported that the envelope protein of PRRSV was rich in glycosylation sites (Ansari et al., [@B3]). The amino terminus of the GP5 protein extracellular domain was highly glycosylated in mature virus (Indik et al., [@B18]) and formed a heterologous dimer with M protein to constitute the main part of the viral capsule and complete the packaging of the virus (Wissink et al., [@B49]). Moreover, GP5 was a key protein for PRRSV invaded cells, and its glycosylation modification for viral infection was essential (Jiang et al., [@B21]). In this experiment, we tried to explore whether B4GALT5 would modify the GP5 and played an antiviral effect. The experimental results (Figure [6](#F6){ref-type="fig"}) show that B4GALT5 interacted with GP5, and it was reported that the steric effect of glycans would have an influence on the conformation of proteins and the formation of multimers (Bager et al., [@B6]). As shown as Figure [3](#F3){ref-type="fig"}, B4GALT5 located in Golgi lumen. Therefore, it was bold speculated that a number of GP5 might be trapped in Golgi lumen because of the interaction of GP5 and B4GALT5. GP5 was unable to participate in the assembly of the virus, so that complete virus particles could not be formed to inhibit the proliferation of the virus. Of course, the above speculations also required a lot of experiments to verify, we hope that following experiments can confirm the above conjectures, to provide new directions and targets for the development of anti-PRRSV infection drugs.

Moreover, the change of transcription and expression level of glycosyltransferase in enveloped virus infection cells may alter the glocoprotein modification on cell membrane, especially, the immune regulation prorein, such as the antigen presenting molecules, immune adhesion molecules and others to regulate the immune response. Macrophages as a class of cells with phagocytosis and antigen presentation were of great significance in the anti-viral immunity (Xie et al., [@B50]). Macrophages could initiate and enhance immune responses through the following two pathways and mediate inflammatory responses (Gajanayaka et al., [@B14]). Firstly, the role of antigen presentation to start immune response; Secondly, the secretion of various types of bioactive substances with immune enhancement effects (Voicu et al., [@B45]; Auray et al., [@B4]; Yu et al., [@B51]), including interferon (IFN-α), interleukin (IL-1β, IL-6, IL-18), chemokines (MCP-1) and receptor (CCR2), adhesion molecules (LFA-1, ICAM-1) (Liu et al., [@B27]), tumor necrosis factor (TNF-α) and antigen presenting molecules (MHC I, II). They could activate the biological function and promote the migration of macrophages. It was reported that all of the above important molecules involved in innate immunity were almost glycoprotein molecules (Krapp et al., [@B24]). In experimental results suggested that the transcription levels of cytokines secreted by macrophage cells had different degrees of upregulation in 3D4/21 cells over-expressed Flag-B4GALT5 that were then infected with the PRRSV at 0.5 MOI (Figures [7B--E](#F7){ref-type="fig"}). Therefore, it was speculated that, in the process of viral infection, B4GALT5 up-regulated the expression of antigen presenting molecules (MHC I, II) and adhesion molecules (LFA-1, ICAM-1) to strengthen the monitoring and presenting of the virus. Meanwhile, B4GALT5 up-regulated the expression of IFN-α and inflammatory factors (IL6, IL-18, IL-1β, TNF-α) to resist viral infection. In addition, B4GALT5 up-regulated the expression of chemokines (MCP-1) and receptor (CCR2), which attract more cells to migrate to the site of infection. They could supervise of pathogen intrusion. In addition, recent studies had shown that polysaccharides had immunomodulatory effects and would enhance non-specific immune function to improve macrophage phagocytosis (Li et al., [@B26]), however, β-1,4 galactosyltransferase might be involved in the synthesis of polysaccharides. The above speculations also need to be verified by the results of subsequent experiments.

In general, studies on β-1, 4 galactosyltransferases will promote the research progress of glycosylation of proteins. However, difficulties are also obvious. The reason is that the process of glycosylation modification is dynamic (Suryavathi et al., [@B40]; Moratz et al., [@B29]), and the connection of glycans is varied. At present, the researches about β-1, 4 galactosyltransferase mainly concentrate in β4GalT1 (Vanhooren et al., [@B44]; Sun et al., [@B39]), especially apoptosis-related regulatory mechanisms (Yuan et al., [@B52]). The studies of β4GalT2-7 remain to be strengthened. With the development of science, we hope that the important function of β-1, 4 galactosyltransferase will be explored in the fields of inflammatory reaction and immune regulation.

Conclusion {#s5}
==========

Porcine B4GALT5 gene, a member of β-1, 4 galactosyltransferase (B4GALT) family, was acquired from porcine alveolar macrophages and located on the Golgi apparatus. The secondary and 3D structure modeling, domain analyses and alignment of amino acid sequence and performed in our study would make achievements by supporting the research of potent mechanisms of β-1, 4 galactosyltransferase V in antiviral immunity. Moreover, the expression of pB4GALT5 would be upregulated by PRRSV infection in 3D4/21 cells, down-regulated the replication of PRRSV by co-located and interaction with the GP5 of PRRSV, which provided new directions and targets for the development of anti-PRRSV infection drugs.
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